Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Yu‐Chong Peng"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Purpose The potential efficacy of metformin in breast cancer (BC) has been hotly discussed but never conclusive. This genetics-based study aimed to evaluate the relationships between metformin targets and BC risk. Methods Metformin targets f
Externí odkaz:
https://doaj.org/article/1829aa2b3194493fa655392f3555b914
Publikováno v:
Annals of Medicine, Vol 55, Iss 2 (2023)
AbstractBackground We aimed to assess differences in intestinal microflora between patients with operable hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) with microvascular invasion (MVI) and those without MVI. Additionally, we investiga
Externí odkaz:
https://doaj.org/article/0b892a3f1c9e40b49a69f4d258ee0571
Publikováno v:
Annals of Medicine, Vol 55, Iss 1 (2023)
AbstractPurpose The purpose of this study was to estimate the clinical efficacy and identify the best beneficiaries of postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) in hepatocellular carcinoma (HCC).Patients and methods A
Externí odkaz:
https://doaj.org/article/e299cf7fe5424e118d986037b4750d4c
Publikováno v:
Journal of International Medical Research, Vol 47 (2019)
Objective A relationship between polymorphisms rs1128503 and rs1045642 in the multidrug resistance 1 gene ( MDR1 ) and susceptibility to hepatocellular carcinoma (HCC) has been reported but is inconclusive. This study was performed to explore the sig
Externí odkaz:
https://doaj.org/article/28362f6a82f8447ca5664f9331ff69e2
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115834 (2014)
BackgroundThe aim of this study was to compare the long-term outcome of patients with a solitary large (> 5 cm) hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) stage A who received liver resection (LR) or transarterial chemoemb
Externí odkaz:
https://doaj.org/article/d4012718b4ac4e5ea7d284ac95bc28d8
Publikováno v:
Clinical Science. 137:303-316
Background: Postoperative transarterial chemoembolization (PA-TACE) is an effective adjuvant therapy for preventing early postoperative recurrence of hepatocellular carcinoma (HCC); however, many patients are insensitive to it. Therefore, the present
Autor:
Lu‐Nan Qi, Liang Ma, Fei‐Xiang Wu, Yuan‐Yuan Chen, Jing‐Xuan Xu, Yu‐Chong Peng, Zu‐Shun Chen, Wen‐Feng Gong, Cheng‐Lei Yang, Hao‐Wen Wei, Shui‐Ling Qin, Jin‐Jie Shang, Qiu‐Yan Wang, Hong‐Ping Yu, Tao Peng, Ying‐Wu Huang, Yong‐Chi Ling, Wei‐Zhong Tang, Bang‐De Xiang, Le‐Qun Li
Publikováno v:
Liver International. 42:2283-2298
The multiplicity of hepatocellular carcinoma (HCC) recurrence patterns is the most important determinant of patients' postsurgical survival. A systematic HCC recurrence classification is needed to help prevent and treat postoperative HCC recurrence i
Publikováno v:
Future Oncology. 18:2113-2125
Aim: To assess whether Ki67 is related to the efficacy of postoperative adjuvant transarterial chemoembolization (PA-TACE) in hepatocellular carcinoma patients at high risk of postsurgical recurrence. Methods: A total of 716 patients undergoing surgi
Publikováno v:
Journal of Gastrointestinal Oncology. 13:326-343
Autor:
Lu-Nan Qi, Liang Ma, Jing-Xuan Xu, Yuan-Yuan Chen, Fei-Xiang Wu, Zu-Shun Chen, Zhan Lu, Min Zhou, Ying-Wu Huang, Yong-Chi Ling, Hai Huang, Yu-Chong Peng, Tao Peng, Bangde Xiang, Le-Qun Li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eed992a83428179a042225e9a27081a0
https://doi.org/10.2139/ssrn.4409345
https://doi.org/10.2139/ssrn.4409345